A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Active, not recruiting	Phase 1 / Phase 2	2026-02-06		NCT03933735

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AbbVie	340

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Atrium Health Levine Cancer Institute /ID# 238786	Charlotte	United States	1
Atrium Health Wake Forest Baptist Medical Center /ID# 238787	Winston-Salem	United States	1
Duplicate_Universitaetsklinikum Muenster /ID# 239637	Münster	Germany	1
Mayo Clinic - Rochester /ID# 238683	Rochester	United States	1
Memorial Sloan Kettering Cancer Center-Koch Center /ID# 244831	New York	United States	1
Mt Sinai /ID# 242317	New York	United States	1
Tulane University School of Medicine /ID# 242322	New Orleans	United States	1
Universitaetsklinikum Carl Gustav Carus Dresden /ID# 239638	Dresden	Germany	1
Universitaetsklinikum Hamburg-Eppendorf /ID# 239636	Hamburg	Germany	1
Universitaetsklinikum Koeln /ID# 239676	Cologne	Germany	1
University of California San Francisco (UCSF) - Parnassus Heights /ID# 238680	San Francisco	United States	1
University of North Carolina /ID# 238685	Chapel Hill	United States	1
Washington University-School of Medicine /ID# 238681	St Louis	United States	1
Wisconsin Medical Center /ID# 238684	Milwaukee	United States	1